Overview
Clinical Meaning
Breast Cancer Screening involves malignant transformation through accumulation of genetic mutations (oncogene activation, tumor suppressor loss) driving uncontrolled proliferation.
PMHNP
PMHNP
Breast Cancer Screening involves malignant transformation through accumulation of genetic mutations (oncogene activation, tumor suppressor loss) driving uncontrolled proliferation. The hallmarks of cancer include sustained proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion/metastasis. TNM staging guides prognosis and treatment decisions. Connect Breast Cancer Screening to bedside cues you will reassess first: vitals trends, work of breathing, perfusion, mentation, and pain or ischemic equivalents when relevant. NCLEX items often reward recognizing when subtle instability outweighs reassurance, then selecting nursing actions that protect airway, circulation, and neurologic status before routine tasks.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this PMHNP pathway. You can still explore topic-filtered questions from the bank hubs below.